The GALANT trial: study protocol of a randomised placebo-controlled trial in patients with a 68Ga-DOTATATE PET-positive, clinically non-functioning pituitary macroadenoma on the effect of lanreotide on tumour size

The GALANT trial: study protocol of a randomised placebo-controlled trial in patients with a 68Ga-DOTATATE PET-positive, clinically non-functioning pituitary macroadenoma on the effect of lanreotide on tumour size

Bibliographic Details
Main Authors:	Jan Booij, Suat Simsek, Tessel M Boertien, Madeleine L Drent, Marcel P M Stokkel, Jantien Hoogmoed, Alberto Pereira, Nienke R Biermasz, Ronald Groote Veldman, Eric Fliers, Peter H Bisschop
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2020-08-01
Series:	BMJ Open
Online Access:	https://bmjopen.bmj.com/content/10/8/e038250.full

Similar Items

68Ga-DOTATATE PET imaging in clinically non-functioning pituitary macroadenomas
by: Tessel M. Boertien, et al.
Published: (2020-02-01)

Therapeutic options in the management of acromegaly: focus on lanreotide Autogel&reg;
by: Ferdin, et al.
Published: (2008-09-01)

The research of Fêtes Galantes I and Fêtes Galantes II
by: Yu-ping Hsu, et al.
Published: (2007)

Dr. Jorge Galante
by: Andres Silberman
Published: (2017-05-01)

A Patient-Reported Outcomes Analysis Of Lanreotide In The Treatment Of NETs Patients With Carcinoid Syndrome: Evidence From The ELECT Trial
by: Blot K, et al.
Published: (2019-10-01)

High prevalence of metabolic syndrome features in patients previously treated for nonfunctioning pituitary macroadenoma.
by: Sjoerd D Joustra, et al.
Published: (2014-01-01)

Medikamentöse Langzeittherapie akromegaler Patienten mit Lanreotid Autogel
by: Kretschmar, Konrad
Published: (2008)

Lanreotide-SDS micelle interactions via NMR spectroscopy
by: Chi-liang Lai, et al.
Published: (2008)

Head and shoulders of Edward G. Galante.
Published: ()

Rationale and design of the RESOLVE trial: lanreotide as a volume reducing treatment for polycystic livers in patients with autosomal dominant polycystic kidney disease
by: Gevers Tom JG, et al.
Published: (2012-04-01)

Clinical utility of lanreotide Autogel® in gastroenteropancreatic neuroendocrine tumors
by: Paragliola RM, et al.
Published: (2016-10-01)

Galant – new sort of tomato for the Far East
by: Galina A. Kuzmitskaya
Published: (2019-11-01)

Mille choses galantes (Dossier A : Corpus)
by: Alain Viala
Published: (2019-03-01)

GALANT REFLEX IN THE DIAGNOSIS OF SPINAL DISORDERS IN NEWBORNS
by: Ольга Александровна Загородникова, et al.
Published: (2019-10-01)

Das galante Modell als kreativer Raum
by: Johannes Raiser
Published: (2018-06-01)

Primary treatment of acromegaly with high-dose lanreotide: a case series
by: Cordes Uwe, et al.
Published: (2010-03-01)

The Use of Lanreotide Autogel® in the Treatment of Intestinal Obstruction in a Patient with Adenocarcinoma
by: Willem Lybaert
Published: (2014-01-01)

Lanreotide Autogel in the Treatment of Persistent Diarrhea following a Total Colectomy
by: Patrick Schoeters, et al.
Published: (2015-01-01)

A case of insulinoma with hypoglycemia that was better managed with lanreotide than octreotide
by: Keiko Yamaoka, et al.
Published: (2021-05-01)

Panhypopituitarism Secondary to Pituitary Macroadenoma
by: Samuel Sánchez Sánchez, et al.
Published: (2021-06-01)

L'égalité des dotations initiales
by: MATHELIER, Guillaume
Published: (2020)

L'égalité des dotations initiales
Published: (2020)

A Study of Debussy’s “Fêtes Galantes I & II”
by: Chin-Chih Yang, et al.
Published: (2015)

Lanreotide Induces Cytokine Modulation in Intestinal Neuroendocrine Tumors and Overcomes Resistance to Everolimus
by: Concetta Sciammarella, et al.
Published: (2020-07-01)

Current treatment options for gastroenteropancreatic neuroendocrine tumors with a focus on the role of lanreotide
by: Beata Kos-Kudła, et al.
Published: (2017-06-01)

The neuropsychological effects of pituitary macroadenomas and their treatment
by: Mark, Daniella
Published: (2014)

Macroadenoma hipofisário: alterações campimétricas visuais
by: Breno Barreto Ribeiro, et al.
Published: (2014-04-01)

Primary hypothyroidism masquerading pituitary macroadenoma
by: Amit Agrawal, et al.
Published: (2014-03-01)

Lutetium Lu-177 Dotatate Flare Reaction
by: Andrew L. Salner, MD, et al.
Published: (2021-01-01)

Efficacy and safety of lanreotide autogel compared with lanreotide 40 mg prolonged release in Chinese patients with active acromegaly: results from a phase 3, prospective, randomized, and open-label study (LANTERN)
by: Zhenmei An, et al.
Published: (2020-05-01)

Initial clinical evaluation of indigenous90Y-DOTATATE in sequential duo-PRRT approach (177Lu-DOTATATE and90Y-DOTATATE) in neuroendocrine tumors with large bulky disease: Observation on tolerability,90Y-DOTATATE post- PRRT imaging characteristics (bremsstrahlung and PETCT) and early adverse effects
by: Rahul V Parghane, et al.
Published: (2021-01-01)

Elocutio: scrupules sur le style galant chez Boisrobert
by: Francisco Guevara Quiel
Published: (2013-11-01)

Harris-Galante II Acetabular Cup: A Survival Analysis
by: HG Curry, et al.
Published: (2008-08-01)

Talking about the limits of legal change: an interview with Marc Galanter
by: Marc Galanter, et al.
Published: (2014-07-01)

A Study of Symbolism Trend in Debussy’s “Fêtes Galantes I”
by: 徐婉婷
Published: (2009)

A Research on the “Fêtes Galantes” Style in Debussy’s Piano Works
by: Tsuen-Hua Huang, et al.
Published: (2012)

A critical translation of Charles Collé's 'Le Galant Escroc'
by: Vasey, Frances
Published: (1999)

Caractérisation biophysique des interactions entre le Lanréotide et des membranes lipidiques
by: Chervy, Pierre
Published: (2017)

Pseudomyxoma Peritonei: Symptom Control and Objective Radiological Response after Treatment with Lanreotide Autogel
by: Gema Marín Zafra, et al.
Published: (2016-01-01)

Treatment with long-acting lanreotide autogel in early infancy in patients with severe neonatal hyperinsulinism
by: Heike Corda, et al.
Published: (2017-06-01)